Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2024

Open Access 01-12-2024 | Research

Identification of predictors for short-term recurrence: comprehensive analysis of 296 retroperitoneal liposarcoma cases

Authors: Zhiyuan Yu, Rui Li, Zhen Yuan, Jiahu Ye, Ping He, Peiyu Li, Yan Sun, Xudong Zhao

Published in: World Journal of Surgical Oncology | Issue 1/2024

Login to get access

Abstract

Background

The short-term (≤ 1 year) recurrence (STR) is the primary determinant impacting both the life quality and survival duration in patients who have undergone surgical resection for retroperitoneal liposarcoma (RPLS), a condition with intricate and ambiguous pathogenesis. The purpose of this study was to analyze the risk factors associated with STR in cases of RPLS and primary retroperitoneal liposarcoma (PRPLS).

Methods

For this retrospective observational study, a total of 296 RPLS cases were selected as research subjects, who experienced tumor recurrence during the follow-up period. The Local recurrence-free survival (LRFS) rates were estimated using the Kaplan–Meier method and subsequently compared between groups utilizing the log-rank test. The subsequent analyses involved univariate and multivariate logistic regression to identify predictors of STR in RPLS cases. Additionally, a logistic regression model was constructed for PRPLS.

Results

The 1-, 3-, and 5-year LRFS rates of the 296 RPLS cases were 51.7%, 16.9%, and 7.1%, respectively. In the univariate analysis, several factors were found to be associated with STR, including preoperative neutrophil/lymphocyte ratio (NLR), smoking history, surgical frequency, combined organ excision, operative time, intraoperative bleeding, transfer to the intensive care unit (ICU), multiple primary tumors, tumor shape and capsule characteristics, histological subtype, and presence of tumor necrosis. The elevated preoperative NLR, surgical frequency of ≥ 3 times, transfer to the ICU, presence of multiple primary tumors, and tumor necrosis were identified as independent risk factors for STR in surgically resected RPLS. Conversely, diabetes, intact tumor capsule, and well-differentiated histological subtype appeared to be independent protective factors. Analysis for PRPLS revealed that tumor capsule and tumor necrosis were independent predictors of STR.

Conclusions

The elevated preoperative NLR, surgical frequency of ≥ 3 times, transfer to the ICU, presence of multiple primary tumors, tumor necrosis, and tumor capsule were expected to serve as predictive factors of STR for surgical resected RPLS and PRPLS.
Literature
1.
go back to reference Bagaria SP, Gabriel E, Mann GN. Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol. 2018;117(1):62–8.CrossRefPubMed Bagaria SP, Gabriel E, Mann GN. Multiply recurrent retroperitoneal liposarcoma. J Surg Oncol. 2018;117(1):62–8.CrossRefPubMed
2.
go back to reference Istl AC, Gronchi A. Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas-Looking Forward. Cancers (Basel). 2022;14(7):1831.CrossRefPubMed Istl AC, Gronchi A. Neoadjuvant Therapy for Primary Resectable Retroperitoneal Sarcomas-Looking Forward. Cancers (Basel). 2022;14(7):1831.CrossRefPubMed
3.
go back to reference Muratori F, Frenos F, Bettini L, Matera D, Mondanelli N, Scorianz M, et al. Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution. J Orthop Sci. 2018;23(6):1038–44.CrossRefPubMed Muratori F, Frenos F, Bettini L, Matera D, Mondanelli N, Scorianz M, et al. Liposarcoma: Clinico-pathological analysis, prognostic factors and survival in a series of 307 patients treated at a single institution. J Orthop Sci. 2018;23(6):1038–44.CrossRefPubMed
4.
go back to reference Salerno KE, Baldini EH. Role of Radiation Therapy in Retroperitoneal Sarcoma. J Natl Compr Canc Netw. 2022;20(7):845–9.CrossRefPubMed Salerno KE, Baldini EH. Role of Radiation Therapy in Retroperitoneal Sarcoma. J Natl Compr Canc Netw. 2022;20(7):845–9.CrossRefPubMed
5.
go back to reference Molina G, Hull MA, Chen YL, DeLaney TF, De Amorim BK, Choy E, et al. Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma. J Surg Oncol. 2016;114(7):814–20.CrossRefPubMed Molina G, Hull MA, Chen YL, DeLaney TF, De Amorim BK, Choy E, et al. Preoperative radiation therapy combined with radical surgical resection is associated with a lower rate of local recurrence when treating unifocal, primary retroperitoneal liposarcoma. J Surg Oncol. 2016;114(7):814–20.CrossRefPubMed
6.
go back to reference Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228(3):355–65.CrossRefPubMedPubMedCentral Lewis JJ, Leung D, Woodruff JM, Brennan MF. Retroperitoneal soft-tissue sarcoma: analysis of 500 patients treated and followed at a single institution. Ann Surg. 1998;228(3):355–65.CrossRefPubMedPubMedCentral
7.
go back to reference Neuhaus SJ, Barry P, Clark MA, Hayes AJ, Fisher C, Thomas JM. Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg. 2005;92(2):246–52.CrossRefPubMed Neuhaus SJ, Barry P, Clark MA, Hayes AJ, Fisher C, Thomas JM. Surgical management of primary and recurrent retroperitoneal liposarcoma. Br J Surg. 2005;92(2):246–52.CrossRefPubMed
8.
go back to reference Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238(3):358–71.CrossRefPubMedPubMedCentral Singer S, Antonescu CR, Riedel E, Brennan MF. Histologic subtype and margin of resection predict pattern of recurrence and survival for retroperitoneal liposarcoma. Ann Surg. 2003;238(3):358–71.CrossRefPubMedPubMedCentral
9.
go back to reference Xue G, Wang Z, Li C, Lv A, Tian X, Wu J, et al. A novel nomogram for predicting local recurrence-free survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center. Int J Clin Oncol. 2021;26(1):145–53.CrossRefPubMed Xue G, Wang Z, Li C, Lv A, Tian X, Wu J, et al. A novel nomogram for predicting local recurrence-free survival after surgical resection for retroperitoneal liposarcoma from a Chinese tertiary cancer center. Int J Clin Oncol. 2021;26(1):145–53.CrossRefPubMed
10.
go back to reference Sánchez-Hidalgo JM, Rufián-Peña S, Durán-Martínez M, Durán-Martínez M, Arjona-Sánchez Á, Salcedo-Leal I, et al. Risk factors of early recurrence in retroperitoneal liposarcoma. Cir Esp (Engl Ed). 2018;96(9):568–76.CrossRefPubMed Sánchez-Hidalgo JM, Rufián-Peña S, Durán-Martínez M, Durán-Martínez M, Arjona-Sánchez Á, Salcedo-Leal I, et al. Risk factors of early recurrence in retroperitoneal liposarcoma. Cir Esp (Engl Ed). 2018;96(9):568–76.CrossRefPubMed
11.
go back to reference Yan Y, Xia S, Teng D, Hu S, Li S, Wang Y, et al. Resection outcomes for primary and local recurrent retroperitoneal liposarcoma patients. Ann Transl Med. 2020;8(21):1450.CrossRefPubMedPubMedCentral Yan Y, Xia S, Teng D, Hu S, Li S, Wang Y, et al. Resection outcomes for primary and local recurrent retroperitoneal liposarcoma patients. Ann Transl Med. 2020;8(21):1450.CrossRefPubMedPubMedCentral
12.
go back to reference Sun P, Ma R, Liu G, Wang L, Chang H, Li Y. Pathological prognostic factors of retroperitoneal liposarcoma: comprehensive clinicopathological analysis of 124 cases. Ann Transl Med. 2021;9(7):574.CrossRefPubMedPubMedCentral Sun P, Ma R, Liu G, Wang L, Chang H, Li Y. Pathological prognostic factors of retroperitoneal liposarcoma: comprehensive clinicopathological analysis of 124 cases. Ann Transl Med. 2021;9(7):574.CrossRefPubMedPubMedCentral
13.
go back to reference Wu YX, Liu JY, Liu JJ, Yan P, Tang B, Cui YH, et al. A retrospective, single-center cohort study on 65 patients with primary retroperitoneal liposarcoma. Oncol Lett. 2018;15(2):1799–810.PubMed Wu YX, Liu JY, Liu JJ, Yan P, Tang B, Cui YH, et al. A retrospective, single-center cohort study on 65 patients with primary retroperitoneal liposarcoma. Oncol Lett. 2018;15(2):1799–810.PubMed
14.
go back to reference Ishii K, Yokoyama Y, Nishida Y, Koike H, Yamada S, Kodera Y, et al. Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institution. Jpn J Clin Oncol. 2020;50(12):1412–8.CrossRefPubMed Ishii K, Yokoyama Y, Nishida Y, Koike H, Yamada S, Kodera Y, et al. Characteristics of primary and repeated recurrent retroperitoneal liposarcoma: outcomes after aggressive surgeries at a single institution. Jpn J Clin Oncol. 2020;50(12):1412–8.CrossRefPubMed
15.
go back to reference Suarez-Kelly LP, Baldi GG, Gronchi A. Pharmacotherapy for liposarcoma: current state of the art and emerging systemic treatments. Expert Opin Pharmacother. 2019;20(12):1503–15.CrossRefPubMed Suarez-Kelly LP, Baldi GG, Gronchi A. Pharmacotherapy for liposarcoma: current state of the art and emerging systemic treatments. Expert Opin Pharmacother. 2019;20(12):1503–15.CrossRefPubMed
16.
go back to reference Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(11):1348–65.CrossRefPubMed Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, et al. Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(11):1348–65.CrossRefPubMed
17.
go back to reference Honoré C, Faron M, Mir O, Haddag-Miliani L, Dumont S, Terrier P, et al. Management of locoregional recurrence after radical resection of a primary nonmetastatic retroperitoneal soft tissue sarcoma: The Gustave Roussy experience. J Surg Oncol. 2018;118(8):1318–25.CrossRefPubMed Honoré C, Faron M, Mir O, Haddag-Miliani L, Dumont S, Terrier P, et al. Management of locoregional recurrence after radical resection of a primary nonmetastatic retroperitoneal soft tissue sarcoma: The Gustave Roussy experience. J Surg Oncol. 2018;118(8):1318–25.CrossRefPubMed
18.
go back to reference Sato T, Yamaguchi T, Azekura K, Ueno M, Ohyama S, Ohya M, et al. Repeated resection for intra-abdominal and retroperitoneal liposarcomas: long-term experience in a single cancer center in Japan. Int Surg. 2006;91(5):267–71.PubMed Sato T, Yamaguchi T, Azekura K, Ueno M, Ohyama S, Ohya M, et al. Repeated resection for intra-abdominal and retroperitoneal liposarcomas: long-term experience in a single cancer center in Japan. Int Surg. 2006;91(5):267–71.PubMed
19.
go back to reference Abdelfatah E, Guzzetta AA, Nagarajan N, Wolfgang CL, Pawlik TM, Choti MA, et al. Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features. J Surg Oncol. 2016;114(1):56–64.CrossRefPubMedPubMedCentral Abdelfatah E, Guzzetta AA, Nagarajan N, Wolfgang CL, Pawlik TM, Choti MA, et al. Long-term outcomes in treatment of retroperitoneal sarcomas: A 15 year single-institution evaluation of prognostic features. J Surg Oncol. 2016;114(1):56–64.CrossRefPubMedPubMedCentral
20.
go back to reference Homsy P, Blomqvist C, Heiskanen I, Vikatmaa L, Tukiainen E, Numminen K, et al. Multidisciplinary Oncovascular Surgery is Safe and Effective in the Treatment of Intra-abdominal and Retroperitoneal Sarcomas: A Retrospective Single Centre Cohort Study and a Comprehensive Literature Review. Eur J Vasc Endovasc Surg. 2020;60(5):752–63.CrossRefPubMed Homsy P, Blomqvist C, Heiskanen I, Vikatmaa L, Tukiainen E, Numminen K, et al. Multidisciplinary Oncovascular Surgery is Safe and Effective in the Treatment of Intra-abdominal and Retroperitoneal Sarcomas: A Retrospective Single Centre Cohort Study and a Comprehensive Literature Review. Eur J Vasc Endovasc Surg. 2020;60(5):752–63.CrossRefPubMed
21.
go back to reference Masaki N, Onozawa M, Inoue T, Kurobe M, Kawai K, Miyazaki J. Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience. Asian J Surg. 2021;44(1):380–5.CrossRefPubMed Masaki N, Onozawa M, Inoue T, Kurobe M, Kawai K, Miyazaki J. Clinical features of multiply recurrent retroperitoneal liposarcoma: A single-center experience. Asian J Surg. 2021;44(1):380–5.CrossRefPubMed
22.
go back to reference Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives. Pathologica. 2021;113(2):70–84.CrossRefPubMed Sbaraglia M, Bellan E, Dei Tos AP. The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives. Pathologica. 2021;113(2):70–84.CrossRefPubMed
23.
go back to reference Littau MJ, Kulshrestha S, Bunn C, Agnew S, Sweigert P, Luchette FA, et al. The importance of the margin of resection and radiotherapy in retroperitoneal liposarcoma. Am J Surg. 2021;221(3):554–60.CrossRefPubMed Littau MJ, Kulshrestha S, Bunn C, Agnew S, Sweigert P, Luchette FA, et al. The importance of the margin of resection and radiotherapy in retroperitoneal liposarcoma. Am J Surg. 2021;221(3):554–60.CrossRefPubMed
24.
go back to reference Dehner CA, Hagemann IS, Chrisinger JSA. Retroperitoneal Dedifferentiated Liposarcoma. Am J Clin Pathol. 2021;156(5):920–5.CrossRefPubMed Dehner CA, Hagemann IS, Chrisinger JSA. Retroperitoneal Dedifferentiated Liposarcoma. Am J Clin Pathol. 2021;156(5):920–5.CrossRefPubMed
25.
go back to reference Simonaggio A, Elaidi R, Fournier L, Fabre E, Ferrari V, Borchiellini D, et al. Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab. Cancer Immunol Immunother. 2020;69(12):2513–22.CrossRefPubMed Simonaggio A, Elaidi R, Fournier L, Fabre E, Ferrari V, Borchiellini D, et al. Variation in neutrophil to lymphocyte ratio (NLR) as predictor of outcomes in metastatic renal cell carcinoma (mRCC) and non-small cell lung cancer (mNSCLC) patients treated with nivolumab. Cancer Immunol Immunother. 2020;69(12):2513–22.CrossRefPubMed
26.
go back to reference Aloe C, Wang H, Vlahos R, Irving L, Steinfort D, Bozinovski S. Emerging and multifaceted role of neutrophils in lung cancer. Transl Lung Cancer Res. 2021;10(6):2806–18.CrossRefPubMedPubMedCentral Aloe C, Wang H, Vlahos R, Irving L, Steinfort D, Bozinovski S. Emerging and multifaceted role of neutrophils in lung cancer. Transl Lung Cancer Res. 2021;10(6):2806–18.CrossRefPubMedPubMedCentral
27.
go back to reference Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–30.CrossRefPubMed Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol. 2013;88(1):218–30.CrossRefPubMed
28.
go back to reference Huangyang P, Li F, Lee P, Nissim I, Weljie AM, Mancuso A, et al. Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis. Cell Metab. 2020;31(1):174–88.CrossRefPubMed Huangyang P, Li F, Lee P, Nissim I, Weljie AM, Mancuso A, et al. Fructose-1,6-Bisphosphatase 2 Inhibits Sarcoma Progression by Restraining Mitochondrial Biogenesis. Cell Metab. 2020;31(1):174–88.CrossRefPubMed
29.
go back to reference Zhuang A, Wu Q, Tong H, Zhang Y, Lu W. Development and Validation of a Nomogram for Predicting Recurrence-Free Survival of Surgical Resected Retroperitoneal Liposarcoma. Cancer Manag Res. 2021;13:6633–9.CrossRefPubMedPubMedCentral Zhuang A, Wu Q, Tong H, Zhang Y, Lu W. Development and Validation of a Nomogram for Predicting Recurrence-Free Survival of Surgical Resected Retroperitoneal Liposarcoma. Cancer Manag Res. 2021;13:6633–9.CrossRefPubMedPubMedCentral
30.
go back to reference Xiao J, Liu J, Chen M, Liu W, He X. Diagnosis and Prognosis of Retroperitoneal Liposarcoma: A Single Asian Center Cohort of 57 Cases. J Oncol. 2021;2021:7594027.CrossRefPubMedPubMedCentral Xiao J, Liu J, Chen M, Liu W, He X. Diagnosis and Prognosis of Retroperitoneal Liposarcoma: A Single Asian Center Cohort of 57 Cases. J Oncol. 2021;2021:7594027.CrossRefPubMedPubMedCentral
Metadata
Title
Identification of predictors for short-term recurrence: comprehensive analysis of 296 retroperitoneal liposarcoma cases
Authors
Zhiyuan Yu
Rui Li
Zhen Yuan
Jiahu Ye
Ping He
Peiyu Li
Yan Sun
Xudong Zhao
Publication date
01-12-2024
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2024
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-024-03328-2

Other articles of this Issue 1/2024

World Journal of Surgical Oncology 1/2024 Go to the issue